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Improvement of Cardiac Function in Acute Murine
Coxsackievirus B 3 Myocarditis by Interferon 2a
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Division of Cardiology, Philipps University, Marburg. FRG
Coxsackievirus B3 infection in male DBAJ2 mice induces severe myocarditis
with infiltration of leukocytes in the myocardium and a deterioration of car-
diac function. Increase of cardiac virus concentration by the administration
of immunosuppressive drugs has lead to an aggravation of the disease.
In order to reduce replicating virus in the heart 600000 units interferon 2a
were intraperitoneally injected on days 2-7 of the infection. On day 9. left
ventricular systolic pressure. left ventricular end-diastolic pressure as well
as +dp/dtmax and -dp/dtmax as parameters for left ventricular systolic and
diastolic function were measured by open chest puncture of the left ventri-
cle. Then the hearts were removed for histology and determination of cardiac
virus concentration.
Cardiac virus titers decreased in the interferon treated mice (log 5.80 vs.
6.22). Hemodynamic parameters of the left ventricle improved in the CVB
3 infected group receiving interferon as compared to untreated infected
mice. Left ventricular systolic pressure rose (84 vs. 71 mmHg; p < 0.05) and
left ventricular enddiastolic pressure decreased significantly (1.39 vs. 2.51
mmHg; p < 0.05). +dp/dtmax (4456 vs. 4375 mmHg/s) and -dp/dtmax (2843
vs. 2540 mmHg/s) were higher in the animals receiving interferon. Hemody-
namic improvement was paralleled by a reduction of myocarditic lesions in
the treated group (2.78 vs. 3.28 on a scale of 0-4; p < 0.05).
Thus. the administration of interferon 2a improves cardiac inflammation
and function in acute coxsackievirus B 3 induced myocarditis. most likely by
reducing viral replication in the heart. This finding underlines the importance
of the virus for mediating cardiac damage in the acute phase of the disease.
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It is controversial if pts with myocarditis(M) benefit from immunosuppressive
therapy. Patients & methods: We report the clinical (NYHA class). hemody-
namic (improvement of LV-ejection fraction (EF) :,:5%). histological (only in-
filtrate(lnf) +1- in HE-staining) and immunohistological(lgG and complement
(C3)-fixation by direct immunofluorescence test in the LV-biopsies) results of
a controlled study inclUding 38 pts randomized in 2 groups. Group 1 was
treated with restraint of physical activity. optional ACE-inhibition. digitalis &
diuretics only. group 2 for 4 weeks with 2 mg/kg/d azathioprin (A) and 1.25
mglkg/d prednisone (P) in addition. After tapering off 0.85 mglkg/A and 0.3
mglkg/d P were given for 2 months. Only pts with an infiltrate and hemody-
namic impairment(EF < 55% and cardiomegaly; LVEDVI > 100 mllm2) were
included. Follow-up (FU) biopsies & hemodynamics were carried out after 3
months. Results (data are given in %. *p < 0.05; improv; improvement; =;
unchanged; deter: deteriorated, Viro: viral etiology likely).
Under treatment with A + P pts improved their NYHA-class and ejection
fraction significantly. Binding of complement, IgG, IgA and IgM in the biopsy
was significantly reduced between both groups. In both treatment arms an
infiltrate. which was obligatory as entrance criterium, was seen only sporad-
ically at follow-up irrespective of the treatment arm (21 vs 15%). In group 2(A
+ P) 4 pts and group 1 (conventional) 5 pts died or went to HTX.
FollOW-Up: Biopsy Serum NYHA-c1ass LV-ejection fraction
Treatment Inl+ IgG+C3 Viro Improv deter unch improv deter unch
conventional 21 95 42 21 21 68 15 26 59
A+P 15 26* 36 53* 21 26* 47* 21 32
Conclusions: Under a combined therapy of A and P patients improved
ejection fraction, NYHA classification and the degree of immunoglobulin and
complement fixation in their biopsies.
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Intracellular Calcium Transients Underlie
Mechanical Restitution in Whole Rat Hearts
Mechanical restitution describes the recovery of myocardial contractility dur-
ing the interval between heart beats. Although restitution has been widely
studied. much of the understanding about restitution of the whole heart has
been inferred from isolated muscle studies. We investigated whether results
from isolated muscle regarding intracellular calcium transients underlying
mechanical restitution could be substantiated in the whole heart. Therefore,
we obtained restitution curves for left ventricular pressure and. simultane-
ously. for intracellular calcium transients in isolated rat hearts (pressure and
calcium plotted as a function of extrasystolic intervals). Intracellular calcium
transients were assessed by surface fluorometry after Indo-1-loading. Resti-
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We found that. similar to isolated muscle. restitution curves for both pres-
sure and intracellular calcium transients in the whole heart followed similar
monoexponential functions. Moreover. interval-dependent changes in pres-
sure were strongly correlated to interval-dependent changes in the ampli-
tude of intracellular calcium transients (correlation by linear regression: r =
0.92, P = 0.00). Thus, for the first time, the results from isolated muscle
regarding intracellular calcium transients underlying mechanical restitution
could be substantiated in the whole heart.
Christian E. Zaugg. Shoji Kojima. Shao T. Wu. Joan Wikman Coffelt. William
W Parmley. Peter T. Buser. University of California San Francisco. San Francisco. CA
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Introduction: ActiVity of the cardiovascular renin-angiotensin systems may
be involved in cardiac remodelling and fibrosis. The absence (Deletion [0])
of a 287 base pair marker in the angiotensin converting enzyme (ACE) gene
(intron 16) has been shown to be associated with raised serum ACE levels.
and DO genotype may be a risk factorforthe development of end-stage heart
failure due to cardiomyopathy. We have therefore examined the relationship
between ACE genotype, the presence of idiopathic dilated cardiomyopathy
(IDC). and markers of disease severity.
Methods: We studied 364 control subjects (age 54 ± 3 years) and 99
consecutive patients (41 ± 14 years) with idiopathic dilated cardiomyopa-
thy (IDC) (left ventricular ejection fraction 25 ± 11 %). 42 were in New York
Heart Association Classification (NYHA) I. 17 in class II. 25 in class III. 15
in class IV DNA was isolated from blood samples. and ACE genotype de-
termined by specific polymerase chain reaction and separation of amplified
fragments by agarose gel electrophoresis. We also compared ACE genotype
distribution to that in previously reported European controls. Functional sta-
tus. clinical course over 28 ± 33 months. and outcome were all documented.
Cardiac morphology and function, and evidence of rhythm disturbance were
non-invasively determined.
Results: ACE genotype distribution and allele frequencies in the control
group, IDC group. and European controls did not differ significantly (p > 0.1
in all cases.) No markers of disease severity or progression other than dura-
tion of symptoms prior to diagnosis and the number of ventricular ectopic
beatslhour were significantly associated with the presence of the DO alleles.
In contrast to previously published reports, we are unable to find evidence
to support an association between ACE genotype and either the diagnosis
of IDC per se. or clinical disease progression.
